ActivistsInvestorsTrumpPoliticiansSerenityCitriniBurrySemianalysisTradeArbitrageSearch

$PSNL:NASDAQ · Personalis Inc - US

Personalis — cancer genomics (MRD testing)

Sector: health

Conviction from: NASDAQCitrini

52-week range: 4.4416.39

2 tracked filer(s) hold this · 0 opened, 1 added, 0 trimmed in 30-JUN-2026

Aggregate 13FScore 52 — mean of 2 scored holder(s) · buyers (new/add) avg 63. Higher = the smart money in this name has the better track record.

Filer13FScoreThis quarterSharesValue% of their book
Paul Tudor Jones / Tudor63Added +31%274,321$3,675,9010.0%
Ancora40Holds (flat)690$9,2460.0%

Beyond 13F — activists, insiders, politicians & research

Insider open-market buys daily digest →

FiledInsiderRoleSharesValue
2026-02-13Tempus AI, Inc.10%-owner320,267$2,739,181Form 4

Citrini Research coverage report library →

ReportDateStance
#80 — Market Memo: January Musings2025-01-09LONG

Every tracked holder of this name, sorted new → added → flat → trimmed. Shares = reported 13F share count; Value as reported (a few managers file values in $thousands). Generated 2026-08-16.